WASHINGTON--(BUSINESS WIRE)--The seemingly simple idea of comparative effectiveness is actually quite complex, finds a new paper issued today by the Biotechnology Industry Organization (BIO). “The Complexities of Comparative Effectiveness,” written by BIO’s Director of Economic Policy Ted Buckley, Ph.D., aims to educate readers about the term “comparative effectiveness” and the conceptual complexities inherent in comparative effectiveness analysis.
